The transmembrane channel-like protein family and human papillomaviruses

References

• Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401:70 - 9; http://dx.doi.org/10.1016/j.virol.2010.02.002; PMID: 20206957
   PubMed Web of Science ®Google Scholar
• de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17 - 27; http://dx.doi.org/10.1016/j.virol.2004.03.033; PMID: 15183049
   PubMed Web of Science ®Google Scholar
• Orth G. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 2006; 18:362 - 74; http://dx.doi.org/10.1016/j.smim.2006.07.008; PMID: 17011789
   PubMed Web of Science ®Google Scholar
• Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations?. Arch Dermatol 2002; 138:649 - 54; http://dx.doi.org/10.1001/archderm.138.5.649; PMID: 12020228
   PubMed Web of Science ®Google Scholar
• Lane JE, Bowman PH, Cohen DJ. Epidermodysplasia verruciformis. South Med J 2003; 96:613 - 5; http://dx.doi.org/10.1097/01.SMJ.0000054544.47233.7C; PMID: 12938792
   PubMed Web of Science ®Google Scholar
• McLaughlin-Drubin ME, Münger K. Oncogenic activities of human papillomaviruses. Virus Res 2009; 143:195 - 208; http://dx.doi.org/10.1016/j.virusres.2009.06.008; PMID: 19540281
   PubMed Web of Science ®Google Scholar
• Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108:712 - 5; http://dx.doi.org/10.1111/1523-1747.ep12292090; PMID: 9129220
   PubMed Web of Science ®Google Scholar
• Hufbauer M, Biddle A, Borgogna C, Gariglio M, Doorbar J, Storey A, Pfister H, Mackenzie I, Akgül B. Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties. J Virol 2013; 87:12158 - 65; http://dx.doi.org/10.1128/JVI.01510-13; PMID: 24006432
   PubMed Web of Science ®Google Scholar
• Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10:550 - 60; http://dx.doi.org/10.1038/nrc2886; PMID: 20592731
   PubMed Web of Science ®Google Scholar
• Stanley M. Immune responses to human papillomavirus. Vaccine 2006; 24:Suppl 1 S16 - 22; http://dx.doi.org/10.1016/j.vaccine.2005.09.002; PMID: 16219398
   PubMed Web of Science ®Google Scholar
• Doorbar J. Latent papillomavirus infections and their regulation. Curr Opin Virol 2013; 3:416 - 21; http://dx.doi.org/10.1016/j.coviro.2013.06.003; PMID: 23816390
   PubMed Web of Science ®Google Scholar
• Ishiji T. Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 2000; 27:73 - 86; PMID: 10721654
   PubMedGoogle Scholar
• Favre M, Ramoz N, Orth G. Human papillomaviruses: general features. Clin Dermatol 1997; 15:181 - 98; http://dx.doi.org/10.1016/S0738-081X(97)00008-4; PMID: 9167903
   PubMed Web of Science ®Google Scholar
• Wallace NA, Gasior SL, Faber ZJ, Howie HL, Deininger PL, Galloway DA. HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition. Virology 2013; 443:69 - 79; http://dx.doi.org/10.1016/j.virol.2013.04.022; PMID: 23706308
   PubMed Web of Science ®Google Scholar
• Kazem S, van der Meijden E, Struijk L, de Gruijl FR, Feltkamp MC. Human papillomavirus 8 E6 disrupts terminal skin differentiation and prevents pro-Caspase-14 cleavage. Virus Res 2012; 163:609 - 16; http://dx.doi.org/10.1016/j.virusres.2011.12.015; PMID: 22230316
   PubMed Web of Science ®Google Scholar
• Mendoza JA, Jacob Y, Cassonnet P, Favre M. Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3. J Virol 2006; 80:12420 - 4; http://dx.doi.org/10.1128/JVI.02576-05; PMID: 17020941
   PubMed Web of Science ®Google Scholar
• Sperling T, Ołdak M, Walch-Rückheim B, Wickenhauser C, Doorbar J, Pfister H, Malejczyk M, Majewski S, Keates AC, Smola S. Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. PLoS Pathog 2012; 8:e1002833; http://dx.doi.org/10.1371/journal.ppat.1002833; PMID: 22911498
   PubMed Web of Science ®Google Scholar
• Iwatsuki K, Nakayama Y, Hamada T, Nakanishi G, Shirafuji Y, Morizane S. Immunological and structural remodeling in human papillomavirus-induced warts and Bowen disease. Eur J Dermatol 2013; Forthcoming PMID: 23644544
   PubMed Web of Science ®Google Scholar
• Byg LM, Vidlund J, Vasiljevic N, Clausen D, Forslund O, Norrild B. NF-κB signalling is attenuated by the E7 protein from cutaneous human papillomaviruses. Virus Res 2012; 169:48 - 53; http://dx.doi.org/10.1016/j.virusres.2012.06.028; PMID: 22776252
   PubMed Web of Science ®Google Scholar
• Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N, Fuchs P, Pfister H. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005; 65:1394 - 400; http://dx.doi.org/10.1158/0008-5472.CAN-04-3263; PMID: 15735026
   PubMed Web of Science ®Google Scholar
• Lazić D, Alborzi F, Marcuzzi GP, Angel P, Hess J, Pfister H, Akgül B. Enhanced StefinA and Sprr2 expression during papilloma formation in HPV8 transgenic mice. J Dermatol Sci 2011; 62:84 - 90; http://dx.doi.org/10.1016/j.jdermsci.2011.02.006; PMID: 21458245
   PubMed Web of Science ®Google Scholar
• Hufbauer M, Lazić D, Reinartz M, Akgül B, Pfister H, Weissenborn SJ. Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets. J Dermatol Sci 2011; 64:7 - 15; http://dx.doi.org/10.1016/j.jdermsci.2011.06.008; PMID: 21763111
   PubMed Web of Science ®Google Scholar
• Dong W, Kloz U, Accardi R, Caldeira S, Tong WM, Wang ZQ, Jansen L, Dürst M, Sylla BS, Gissmann L, et al. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 2005; 79:14899 - 908; http://dx.doi.org/10.1128/JVI.79.23.14899-14908.2005; PMID: 16282489
   PubMed Web of Science ®Google Scholar
• Michel A, Kopp-Schneider A, Zentgraf H, Gruber AD, de Villiers EM. E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 2006; 80:11153 - 64; http://dx.doi.org/10.1128/JVI.00954-06; PMID: 16971438
   PubMed Web of Science ®Google Scholar
• Buitrago-Pérez Á, Hachimi M, Dueñas M, Lloveras B, Santos A, Holguín A, Duarte B, Santiago JL, Akgül B, Rodríguez-Peralto JL, et al. A humanized mouse model of HPV-associated pathology driven by E7 expression. PLoS One 2012; 7:e41743; http://dx.doi.org/10.1371/journal.pone.0041743; PMID: 22911850
   PubMed Web of Science ®Google Scholar
• Lewandowsky F, Lutz W. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch Derm Syphilol 1922; 141:193; http://dx.doi.org/10.1007/BF01938833
   Google Scholar
• Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984; 83:Suppl 18s - 25s; http://dx.doi.org/10.1111/1523-1747.ep12281128; PMID: 6330217
   PubMed Web of Science ®Google Scholar
• Orth G, Jablonska S, Jarzabek-Chorzelska M, Obalek S, Rzesa G, Favre M, Croissant O. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 1979; 39:1074 - 82; PMID: 218721
   PubMed Web of Science ®Google Scholar
• Astori G, Lavergne D, Benton C, Höckmayr B, Egawa K, Garbe C, de Villiers EM. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998; 110:752 - 5; http://dx.doi.org/10.1046/j.1523-1747.1998.00191.x; PMID: 9579540
   PubMed Web of Science ®Google Scholar
• Antonsson A, Karanfilovska S, Lindqvist PG, Hansson BG. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003; 41:2509 - 14; http://dx.doi.org/10.1128/JCM.41.6.2509-2514.2003; PMID: 12791874
   PubMed Web of Science ®Google Scholar
• Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J, Majewski S, Pfister H, Wieland U. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005; 125:93 - 7; http://dx.doi.org/10.1111/j.0022-202X.2005.23733.x; PMID: 15982308
   PubMed Web of Science ®Google Scholar
• Stark S, Petridis AK, Ghim SJ, Jenson AB, Bouwes Bavinck JN, Gross G, Stockfleth E, Fuchs PG, Pfister H. Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 1998; 111:696 - 701; http://dx.doi.org/10.1046/j.1523-1747.1998.00360.x; PMID: 9764856
   PubMed Web of Science ®Google Scholar
• Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998; 110:311 - 7; http://dx.doi.org/10.1046/j.1523-1747.1998.00164.x; PMID: 9540967
   PubMed Web of Science ®Google Scholar
• Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999; 112:259 - 63; http://dx.doi.org/10.1046/j.1523-1747.1999.00536.x; PMID: 10084299
   PubMed Web of Science ®Google Scholar
• Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32:579 - 81; http://dx.doi.org/10.1038/ng1044; PMID: 12426567
   PubMed Web of Science ®Google Scholar
• Ramoz N, Taïeb A, Rueda LA, Montoya LS, Bouadjar B, Favre M, Orth G. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000; 114:1148 - 53; http://dx.doi.org/10.1046/j.1523-1747.2000.00996.x; PMID: 10844558
   PubMed Web of Science ®Google Scholar
• Crequer A, Picard C, Patin E, D’Amico A, Abhyankar A, Munzer M, Debré M, Zhang SY, de Saint-Basile G, Fischer A, et al. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PLoS One 2012; 7:e44010; http://dx.doi.org/10.1371/journal.pone.0044010; PMID: 22952854
   PubMed Web of Science ®Google Scholar
• Oh KS, Khan SG, Jaspers NG, Raams A, Ueda T, Lehmann A, Friedmann PS, Emmert S, Gratchev A, Lachlan K, et al. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat 2006; 27:1092 - 103; http://dx.doi.org/10.1002/humu.20392; PMID: 16947863
   PubMed Web of Science ®Google Scholar
• Nehme NT, Pachlopnik Schmid J, Debeurme F, André-Schmutz I, Lim A, Nitschke P, Rieux-Laucat F, Lutz P, Picard C, Mahlaoui N, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 2012; 119:3458 - 68; http://dx.doi.org/10.1182/blood-2011-09-378364; PMID: 22174160
   PubMed Web of Science ®Google Scholar
• Avruch J, Zhou D, Fitamant J, Bardeesy N. Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development. Br J Cancer 2011; 104:24 - 32; http://dx.doi.org/10.1038/sj.bjc.6606011; PMID: 21102585
   PubMed Web of Science ®Google Scholar
• Tan MJ, White EA, Sowa ME, Harper JW, Aster JC, Howley PM. Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc Natl Acad Sci U S A 2012; 109:E1473 - 80; http://dx.doi.org/10.1073/pnas.1205991109; PMID: 22547818
   PubMed Web of Science ®Google Scholar
• Crequer A, Troeger A, Patin E, Ma CS, Picard C, Pedergnana V, Fieschi C, Lim A, Abhyankar A, Gineau L, et al. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest 2012; 122:3239 - 47; http://dx.doi.org/10.1172/JCI62949; PMID: 22850876
   PubMed Web of Science ®Google Scholar
• Tybulewicz VL, Henderson RB. Rho family GTPases and their regulators in lymphocytes. Nat Rev Immunol 2009; 9:630 - 44; http://dx.doi.org/10.1038/nri2606; PMID: 19696767
   PubMed Web of Science ®Google Scholar
• Zavattaro E, Azzimonti B, Mondini M, De Andrea M, Borgogna C, Dell’Oste V, Ferretti M, Nicola S, Cappellano G, Carando A, et al. Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J Invest Dermatol 2008; 128:732 - 5; http://dx.doi.org/10.1038/sj.jid.5701124; PMID: 17960179
   PubMed Web of Science ®Google Scholar
• Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Fischer A, Franco JL, Geha RS, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011; 2:54; PMID: 22566844
   PubMed Web of Science ®Google Scholar
• Majewski S, Malejczyk J, Jablonska S, Misiewicz J, Rudnicka L, Obalek S, Orth G. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1990; 22:423 - 7; http://dx.doi.org/10.1016/0190-9622(90)70058-P; PMID: 2155952
   PubMed Web of Science ®Google Scholar
• Cooper KD, Androphy EJ, Lowy D, Katz SI. Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol 1990; 94:769 - 76; http://dx.doi.org/10.1111/1523-1747.ep12874631; PMID: 2162366
   PubMed Web of Science ®Google Scholar
• Prawer SE, Pass F, Vance JC, Greenberg LJ, Yunis EJ, Zelickson AS. Depressed immune function in epidermodysplasia verruciformis. Arch Dermatol 1977; 113:495 - 9; http://dx.doi.org/10.1001/archderm.1977.01640040103018; PMID: 848981
   PubMed Web of Science ®Google Scholar
• Gliński W, Jablonska S, Langner A, Obalek S, Haftek M, Proniewska M. Cell-mediated immunity in epidermodysplasia verruciformis. Dermatologica 1976; 153:218 - 27; http://dx.doi.org/10.1159/000251060; PMID: 1017532
   PubMedGoogle Scholar
• Pereira de Oliveira WR, Carrasco S, Neto CF, Rady P, Tyring SK. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. J Dermatol 2003; 30:203 - 9; PMID: 12692356
   PubMed Web of Science ®Google Scholar
• Gliński W, Obałek S, Jabłońska S, Orth G. T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5. Dermatologica 1981; 162:141 - 7; http://dx.doi.org/10.1159/000250262; PMID: 6265297
   PubMedGoogle Scholar
• Majewski S, Skopinska-Rozewska E, Jabłonska S, Wasik M, Misiewicz J, Orth G. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986; 15:966 - 73; http://dx.doi.org/10.1016/S0190-9622(86)70258-2; PMID: 3491095
   PubMed Web of Science ®Google Scholar
• Crequer A, Picard C, Pedergnana V, Lim A, Zhang SY, Abel L, Majewski S, Casanova JL, Jablonska S, Orth G, et al. EVER2 deficiency is associated with mild T-cell abnormalities. J Clin Immunol 2013; 33:14 - 21; http://dx.doi.org/10.1007/s10875-012-9749-1; PMID: 22903682
   PubMed Web of Science ®Google Scholar
• Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance. Am J Med Sci 1992; 304:174 - 9; http://dx.doi.org/10.1097/00000441-199209000-00006; PMID: 1335684
   PubMed Web of Science ®Google Scholar
• Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, Engler DE, Grossman ME. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 2009; 60:315 - 20; http://dx.doi.org/10.1016/j.jaad.2008.08.035; PMID: 19150275
   PubMed Web of Science ®Google Scholar
• Kaushal A, Silver S, Kasper K, Severini A, Hamza S, Keynan Y. Epidermodysplasia verruciformis in an HIV-infected man: a case report and review of the literature. Top Antivir Med 2012; 20:173 - 9; PMID: 23363696
   PubMedGoogle Scholar
• Jacobelli S, Laude H, Carlotti A, Rozenberg F, Deleuze J, Morini JP, Franck N, Gorin I, Avril MF, Dupin N. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Arch Dermatol 2011; 147:590 - 6; http://dx.doi.org/10.1001/archdermatol.2010.399; PMID: 21242344
   PubMed Web of Science ®Google Scholar
• Morrison C, Eliezri Y, Magro C, Nuovo GJ. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients. J Cutan Pathol 2002; 29:480 - 9; http://dx.doi.org/10.1034/j.1600-0560.2002.290806.x; PMID: 12207742
   PubMed Web of Science ®Google Scholar
• Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S. Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J Am Acad Dermatol 2007; 57:Suppl S78 - 80; http://dx.doi.org/10.1016/j.jaad.2006.04.035; PMID: 17938030
   PubMedGoogle Scholar
• Holmes C, Chong AH, Tabrizi SN, Downes N, Nindl I. Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosus. Australas J Dermatol 2009; 50:44 - 7; http://dx.doi.org/10.1111/j.1440-0960.2008.00502.x; PMID: 19178492
   PubMed Web of Science ®Google Scholar
• de Oliveira WR, Festa Neto C, Rady PL, Tyring SK. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2003; 17:394 - 8; http://dx.doi.org/10.1046/j.1468-3083.2003.00703.x; PMID: 12834447
   PubMed Web of Science ®Google Scholar
• Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw 2010; 8:888 - 96; PMID: 20870635
   PubMed Web of Science ®Google Scholar
• Patel T, Morrison LK, Rady P, Tyring S. Epidermodysplasia verruciformis and susceptibility to HPV. Dis Markers 2010; 29:199 - 206; http://dx.doi.org/10.1155/2010/345436; PMID: 21178278
   PubMed Web of Science ®Google Scholar
• Iftner A, Klug SJ, Garbe C, Blum A, Stancu A, Wilczynski SP, Iftner T. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003; 63:7515 - 9; PMID: 14612553
   PubMed Web of Science ®Google Scholar
• Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, Dillner J, de Villiers EM, Viraskin Study Group. Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196:876 - 83; http://dx.doi.org/10.1086/521031; PMID: 17703418
   PubMed Web of Science ®Google Scholar
• Au WW, Wilkinson GS, Tyring SK, Legator MS, el Zein R, Hallberg L, Heo MY. Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect 1996; 104:Suppl 3 579 - 84; PMID: 8781386
   PubMed Web of Science ®Google Scholar
• Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997; 13:410 - 4; http://dx.doi.org/10.1016/S0168-9525(97)01246-8; PMID: 9351343
   PubMed Web of Science ®Google Scholar
• Brash DE, Pontén J. Skin precancer. Cancer Surv 1998; 32:69 - 113; PMID: 10489624
   PubMedGoogle Scholar
• Padlewska K, Ramoz N, Cassonnet P, Riou G, Barrois M, Majewski S, Croissant O, Jablonska S, Orth G. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J Invest Dermatol 2001; 117:935 - 42; http://dx.doi.org/10.1046/j.0022-202x.2001.01515.x; PMID: 11676835
   PubMed Web of Science ®Google Scholar
• Purdie KJ, Pennington J, Proby CM, Khalaf S, de Villiers EM, Leigh IM, Storey A. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J 1999; 18:5359 - 69; http://dx.doi.org/10.1093/emboj/18.19.5359; PMID: 10508168
   PubMed Web of Science ®Google Scholar
• Akgül B, Lemme W, García-Escudero R, Storey A, Pfister HJ. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch Virol 2005; 150:145 - 51; http://dx.doi.org/10.1007/s00705-004-0398-4; PMID: 15654507
   PubMed Web of Science ®Google Scholar
• Shurin MR, Yurkovetsky ZR, Tourkova IL, Balkir L, Shurin GV. Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int J Cancer 2002; 101:61 - 8; http://dx.doi.org/10.1002/ijc.10576; PMID: 12209589
   PubMed Web of Science ®Google Scholar
• Bachmann F, Buechner SA, Wernli M, Strebel S, Erb P. Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol 2001; 117:59 - 66; http://dx.doi.org/10.1046/j.0022-202x.2001.01380.x; PMID: 11442750
   PubMed Web of Science ®Google Scholar
• Erb P, Ji J, Kump E, Mielgo A, Wernli M. Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 2008; 624:283 - 95; http://dx.doi.org/10.1007/978-0-387-77574-6_22; PMID: 18348464
   PubMed Web of Science ®Google Scholar
• Jackson S, Ghali L, Harwood C, Storey A. Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus. Br J Cancer 2002; 87:319 - 23; http://dx.doi.org/10.1038/sj.bjc.6600431; PMID: 12177802
   PubMed Web of Science ®Google Scholar
• Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000; 14:3065 - 73; http://dx.doi.org/10.1101/gad.182100; PMID: 11114894
   PubMed Web of Science ®Google Scholar
• Leverrier S, Bergamaschi D, Ghali L, Ola A, Warnes G, Akgül B, Blight K, García-Escudero R, Penna A, Eddaoudi A, et al. Role of HPV E6 proteins in preventing UVB-induced release of pro-apoptotic factors from the mitochondria. Apoptosis 2007; 12:549 - 60; http://dx.doi.org/10.1007/s10495-006-0004-1; PMID: 17195958
   PubMed Web of Science ®Google Scholar
• Muschik D, Braspenning-Wesch I, Stockfleth E, Rösl F, Hofmann TG, Nindl I. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS One 2011; 6:e27655; http://dx.doi.org/10.1371/journal.pone.0027655; PMID: 22110707
   PubMed Web of Science ®Google Scholar
• Tomlins C, Storey A. Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. Carcinogenesis 2010; 31:2155 - 64; http://dx.doi.org/10.1093/carcin/bgq200; PMID: 20884685
   PubMed Web of Science ®Google Scholar
• Guerrini JS, Bouvard V, Oswald E, Alonso A, Prétet JL, Tommasino M, Mougin C, Aubin F. E6 and E7 proteins from different beta-papillomaviruses types do not interfere in UVB-induced apoptosis of HaCaT keratinocytes. Exp Dermatol 2011; 20:71 - 3; http://dx.doi.org/10.1111/j.1600-0625.2010.01197.x; PMID: 21158941
   PubMed Web of Science ®Google Scholar
• Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T. UV-induced skin damage. Toxicology 2003; 189:21 - 39; http://dx.doi.org/10.1016/S0300-483X(03)00150-1; PMID: 12821280
   PubMed Web of Science ®Google Scholar
• Wallace NA, Robinson K, Howie HL, Galloway DA. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. PLoS Pathog 2012; 8:e1002807; http://dx.doi.org/10.1371/journal.ppat.1002807; PMID: 22807682
   PubMed Web of Science ®Google Scholar
• Iftner T, Elbel M, Schopp B, Hiller T, Loizou JI, Caldecott KW, Stubenrauch F. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 2002; 21:4741 - 8; http://dx.doi.org/10.1093/emboj/cdf443; PMID: 12198176
   PubMed Web of Science ®Google Scholar
• Giampieri S, Storey A. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 2004; 90:2203 - 9; PMID: 15150558
   PubMed Web of Science ®Google Scholar
• Kurima K, Yang Y, Sorber K, Griffith AJ. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 2003; 82:300 - 8; http://dx.doi.org/10.1016/S0888-7543(03)00154-X; PMID: 12906855
   PubMed Web of Science ®Google Scholar
• Keresztes G, Mutai H, Heller S. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 2003; 4:24; http://dx.doi.org/10.1186/1471-2164-4-24; PMID: 12812529
   PubMed Web of Science ®Google Scholar
• Kurima K, Peters LM, Yang Y, Riazuddin S, Ahmed ZM, Naz S, Arnaud D, Drury S, Mo J, Makishima T, et al. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet 2002; 30:277 - 84; http://dx.doi.org/10.1038/ng842; PMID: 11850618
   PubMed Web of Science ®Google Scholar
• Vreugde S, Erven A, Kros CJ, Marcotti W, Fuchs H, Kurima K, Wilcox ER, Friedman TB, Griffith AJ, Balling R, et al. Beethoven, a mouse model for dominant, progressive hearing loss DFNA36. Nat Genet 2002; 30:257 - 8; http://dx.doi.org/10.1038/ng848; PMID: 11850623
   PubMed Web of Science ®Google Scholar
• Hahn Y, Kim DS, Pastan IH, Lee B. Anoctamin and transmembrane channel-like proteins are evolutionarily related. Int J Mol Med 2009; 24:51 - 5; http://dx.doi.org/10.3892/ijmm_00000205; PMID: 19513534
   PubMed Web of Science ®Google Scholar
• Steel KP, Bock GR. The nature of inherited deafness in deafness mice. Nature 1980; 288:159 - 61; http://dx.doi.org/10.1038/288159a0; PMID: 7432512
   PubMed Web of Science ®Google Scholar
• Chatzigeorgiou M, Bang S, Hwang SW, Schafer WR. tmc-1 encodes a sodium-sensitive channel required for salt chemosensation in C. elegans. Nature 2013; 494:95 - 9; http://dx.doi.org/10.1038/nature11845; PMID: 23364694
   PubMed Web of Science ®Google Scholar
• Kim KX, Beurg M, Hackney CM, Furness DN, Mahendrasingam S, Fettiplace R. The role of transmembrane channel-like proteins in the operation of hair cell mechanotransducer channels. J Gen Physiol 2013; 142:493 - 505; http://dx.doi.org/10.1085/jgp.201311068; PMID: 24127526
   PubMed Web of Science ®Google Scholar
• Nielsen M, Lundegaard C, Lund O, Petersen TN. CPHmodels-3.0--remote homology modeling using structure-guided sequence profiles. Nucleic Acids Res 2010; 38:W576 - 81; http://dx.doi.org/10.1093/nar/gkq535; PMID: 20542909
   PubMed Web of Science ®Google Scholar
• Chang HY, Choi SK, Vakkasoglu AS, Chen Y, Hemp J, Fee JA, Gennis RB. Exploring the proton pump and exit pathway for pumped protons in cytochrome ba3 from Thermus thermophilus. Proc Natl Acad Sci U S A 2012; 109:5259 - 64; http://dx.doi.org/10.1073/pnas.1107345109; PMID: 22431640
   PubMed Web of Science ®Google Scholar
• Wouters MA, Fan SW, Haworth NL. Disulfides as redox switches: from molecular mechanisms to functional significance. Antioxid Redox Signal 2010; 12:53 - 91; http://dx.doi.org/10.1089/ars.2009.2510; PMID: 19634988
   PubMed Web of Science ®Google Scholar
• Tate G, Suzuki T, Kishimoto K, Mitsuya T. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J Hum Genet 2004; 49:223 - 5; http://dx.doi.org/10.1007/s10038-004-0135-6; PMID: 15042430
   PubMed Web of Science ®Google Scholar
• Sun XK, Chen JF, Xu AE. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol 2005; 30:573 - 4; http://dx.doi.org/10.1111/j.1365-2230.2005.01858.x; PMID: 16045695
   PubMed Web of Science ®Google Scholar
• Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004; 101:6062 - 7; http://dx.doi.org/10.1073/pnas.0400782101; PMID: 15075390
   PubMed Web of Science ®Google Scholar
• Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008; 205:35 - 42; http://dx.doi.org/10.1084/jem.20071311; PMID: 18158319
   PubMed Web of Science ®Google Scholar
• Peto M, Tolle-Ersü I, Kreysch HG, Klock G. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. J Gen Virol 1995; 76:1945 - 58; http://dx.doi.org/10.1099/0022-1317-76-8-1945; PMID: 7636475
   PubMed Web of Science ®Google Scholar
• Kyo S, Klumpp DJ, Inoue M, Kanaya T, Laimins LA. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol 1997; 78:401 - 11; PMID: 9018063
   PubMed Web of Science ®Google Scholar
• Lazarczyk M, Favre M. Role of Zn2+ ions in host-virus interactions. J Virol 2008; 82:11486 - 94; http://dx.doi.org/10.1128/JVI.01314-08; PMID: 18787005
   PubMed Web of Science ®Google Scholar
• Bravo IG, Alonso A. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol 2004; 78:13613 - 26; http://dx.doi.org/10.1128/JVI.78.24.13613-13626.2004; PMID: 15564472
   PubMed Web of Science ®Google Scholar
• Beskow AH, Rönnholm J, Magnusson PK, Gyllensten UB. Susceptibility locus for epidermodysplasia verruciformis not linked to cervical cancer in situ. Hereditas 2001; 135:61 - 3; http://dx.doi.org/10.1111/j.1601-5223.2001.00061.x; PMID: 12035615
   PubMed Web of Science ®Google Scholar
• Castro FA, Ivansson EL, Schmitt M, Juko-Pecirep I, Kjellberg L, Hildesheim A, Gyllensten UB, Pawlita M. Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer 2012; 130:349 - 55; http://dx.doi.org/10.1002/ijc.26016; PMID: 21387292
   PubMed Web of Science ®Google Scholar
• Carré D, Dompmartin A, Verdon R, Comoz F, Le Brun E, Freymuth F, Leroy D. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol 2003; 42:296 - 300; http://dx.doi.org/10.1046/j.1365-4362.2003.01707_2.x; PMID: 12694498
   PubMed Web of Science ®Google Scholar
• Lazarczyk M, Dalard C, Hayder M, Dupre L, Pignolet B, Majewski S, Vuillier F, Favre M, Liblau RS. EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One 2012; 7:e39995; http://dx.doi.org/10.1371/journal.pone.0039995; PMID: 22761942
   PubMed Web of Science ®Google Scholar
• Gaud G, Guillemot D, Jacob Y, Favre M, Vuillier F. EVER2 protein binds TRADD to promote TNF-α-induced apoptosis. Cell Death Dis 2013; 4:e499; http://dx.doi.org/10.1038/cddis.2013.27; PMID: 23429285
   PubMed Web of Science ®Google Scholar
• Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 2004; 4:46 - 54; http://dx.doi.org/10.1038/nri1260; PMID: 14704767
   PubMed Web of Science ®Google Scholar